Submit Your Feeds

Business News • PR NewsWire • Mirati Therapeutics To Present Preclinical And Clinical Data At The IASLC 16th World Conference On Lung Cancer

Mirati Therapeutics To Present Preclinical And Clinical Data At The IASLC 16th World Conference On Lung Cancer
Mirati Therapeutics To Present Preclinical And Clinical Data At The IASLC 16th World Conference On Lung Cancer

SAN DIEGO, Aug. 21, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX), an oncology company focusing on genetic and epigenetic drivers of cancer, today announced it will present data on its two tyrosine kinase inhibitors, MGCD265 and MGCD516, at the...

View More : http://www.prnewswire.com/news-releases/mirati-therapeutics-to-present-preclinical-and-clinical-data-at-the-iaslc-16th-w...
Releted News by prnewswire
Walt Disney Records Announce The Final Four Releases In The Walt Disney Records The Legacy Collection Series: "Lady And The Tramp", "Pocahontas", "The Aristocats", And "Disneyland"
Mirati Therapeutics To Present Preclinical And Clinical Data At The IASLC 16th World Conference On Lung Cancer
Home Sitemap Contact Us
© businessNewsNewsNews.com